Robert Cascella, Director at Neuronetics, Inc. (STIM), bought 28,500 shares at $1.81 ($52K) on 2023-08-10, disclosed to the SEC on 2023-09-20.
Open-market purchase of $52k STIM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| STIM | BUY | 2024-08-16 | $58K | — | Filing → |
| STIM | BUY | 2024-06-06 | $205K | — | Filing → |
| KRMD | BUY | 2023-08-17 | $50K | — | Filing → |